Get the Stockscreener App
0.5291
14.13%
0.0655
After Hours:
.90
0.3709
+70.10%
Glucotrack Inc stock is traded at $0.5291, with a volume of 533.85K.
It is up +14.13% in the last 24 hours and up +36.93% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$0.4636
Open:
$0.469
24h Volume:
533.85K
Relative Volume:
0.12
Market Cap:
$3.31M
Revenue:
-
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.0253
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
+46.97%
1M Performance:
+36.93%
6M Performance:
-85.66%
1Y Performance:
-90.64%
1-Day Range:
$0.44
$0.5495
1-Week Range:
$0.3197
$0.5495
52-Week Range:
$0.2907
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.5291 | 2.90M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
379.50 | 144.19B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
150.65 | 42.39B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.66 | 34.31B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.86 | 33.65B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
193.01 | 28.79B | 5.54B | 1.52B | 1.74B | 10.37 |
Glucotrack Inc Stock (GCTK) Latest News
Glucotrack and Lōkahi Therapeutics Complete Strategic - GlobeNewswire
After Lōkahi Deal, Glucotrack’s Glucose Tech Will Run Separately - Stock Titan
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
Glucotrack expands IP to cover novel glucose monitor sensor architectures - Drug Delivery Business
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM - Yahoo Finance
Glucotrack Issued Notice of Allowance by USPTO for Patent Application Covering Implantable CBGM Platform - citybiz
Glucotrack receives patent allowance for glucose monitoring system - Investing.com
GlucoTrack Issued US Patent Office Allowance for Blood Glucose Monitoring System - marketscreener.com
Glucotrack receives patent allowance for glucose monitoring system By Investing.com - Investing.com Canada
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform - The Manila Times
Glucotrack Announces USPTO Notice Of Allowance For Patent Application Covering Its Implantable CBGM Platform - Menafn
Glucotrack patent wins USPTO notice as implantable glucose monitor advances - Stock Titan
GlucoTrack Inc. (GCTK) Holds Near Support Despite Modest DeclineLarge Cap Trends - DonanımHaber
GlucoTrack Stock Declines 5% as Shares Test Key Support at $0.31Volume Breakout Ideas - dars.gov.et
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to sales forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
Price to book forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
GlucoTrack Inc (GCTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GlucoTrack Inc (GCTK) Institutional Confidence - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Glucotrack (NASDAQ: GCTK) seeks reverse split, warrant repricing and auditor ratification - Stock Titan
EBIT per share of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt Inc Ordinary Shares (NASDAQ:ADTX) - Benzinga
GLUCOTRACK INC (GCTK) Stock Chart - ChartMill
GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
Glucotrack CEO explains tech behind long-term CBGM implant - Drug Delivery Business
GCTKGlucoTrack Inc Short Interest - Finviz
Glucotrack Inc Highlights Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association 2026 Scientific Sessions - marketscreener.com
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - The Manila Times
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions - Moomoo
Implantable glucose sensor designed for multi-year use without wearables - Stock Titan
GlucoTrack Inc. (GCTK) Surges 8%: Testing Key Resistance at $0.53PCR Spike - The Legal Advocate
GlucoTrack Inc. (GCTK) Rallies 8.23% as Shares Test Key Resistance LevelBlock Trade Flow - thelegaladvocate.com
GlucoTrack Inc. (GCTK) Rebounds Sharply: Bullish Momentum Building Above SupportContinuation Pattern Picks - The Legal Advocate
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
GlucoTrack Faces Multiple Nasdaq Deficiency Notices, Delisting Risk - TipRanks
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies By Investing.com - Investing.com South Africa
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies - Investing.com
Glucotrack Received Notice of Delisting - TradingView
Glucotrack (GCTK) cited for bid price and equity Nasdaq deficiencies - Stock Titan
Armistice Capital (GCTK) reports 102,115 shares, 4.99% ownership - Stock Titan
Glucotrack Reports Q1 2026 Results and Advances IDE Submission for Implantable Glucose Monitor - Minichart
Glucotrack's 3-Year CGM Aims to Revolutionize Diabetes Management - BriefGlance
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):